Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Canada’s New Rare Disease Registry Guidance To Assist Regulatory And HTA Decision Making
Mar 05 2025
•
By
Francesca Bruce
New guidance on rare disease registries in Canada will help regulators and HTA bodies identify quality data sources for decision-making.
(Shutterstock)
More from Canada
More from Rare Diseases